Merck shares rise after Barclays upgrades shares, downgrades competitor Pfizer

Barclays upgraded Merck to overweight from equal weight on better opportunities versus its competition, while downgrading Pfizer to equal weight from overweight given the less likely chance of a "transformative" acquisition.

from Mergers and Acquisitions https://ift.tt/2GWSK5m